REAP Financial Group’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$153K Buy
646
+15
+2% +$3.12K 0.03% 164
2026
Q1
$133K Buy
631
+6
+1% +$1.29K 0.03% 172
2025
Q4
$128K Buy
625
+94
+18% +$17.7K 0.03% 168
2025
Q3
$83.4K Buy
531
+50
+10% +$7.72K 0.02% 208
2025
Q2
$80.8K Buy
481
+383
+391% +$56.8K 0.02% 208
2025
Q1
$13.5K Buy
98
+25
+34% +$3.19K ﹤0.01% 343
2024
Q4
$8.58K Hold
73
﹤0.01% 384
2024
Q3
$8.12K Sell
73
-4
-5% -$418 ﹤0.01% 396
2024
Q2
$7.6K Buy
77
+4
+5% +$408 ﹤0.01% 375
2024
Q1
$8.18K Sell
73
-22
-23% -$2.37K ﹤0.01% 395
2023
Q4
$9.59K Buy
+95
New +$9.43K ﹤0.01% 402

Other funds holding CAH

REAP Financial Group's CAH Position: Q2 2026 in Review

REAP Financial Group increased its Cardinal Health (CAH) stake by 2.4% in Q2 2026, buying an estimated $3.12K and bringing the position to 646 shares worth $153K. The position accounts for 0.03% of the portfolio, ranked #164.

REAP Financial Group first reported a position in CAH in Q4 2023 and has held it in 11 quarters since. 1,492 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • REAP Financial Group held 646 shares of Cardinal Health worth $153K as of Q2 2026.
  • REAP Financial Group bought 15 Cardinal Health shares in Q2 2026, an estimated $3.12K.
  • Cardinal Health made up 0.03% of REAP Financial Group's portfolio in Q2 2026, its #164 holding.
  • REAP Financial Group first reported a position in Cardinal Health in Q4 2023 and has held it in 11 quarters since.
  • 1,492 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on REAP Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.